SahmAdrangi is the originator and founder of Kerrisdale Capital Management where he also acts as Chief Investment Officer. Since the start of Kerrisdale Capital in 2009, Adrangi has been involved and at the forefront of all operations of the development of the company. The firm was originally launched with less than $1 million of capital and as of July of 2017 had $150 million under management.
SahmAdrangi is well-known for his strategies of selling short and for the published results of those transactions. The focus of such information touches on the subjects of long transactions that are not followed correctly and short sells that are over-hyped. These business prospects that are subject to many misconceptions are covered by SahmAdrangi and his firm. The research of Kerrisdale is widely available on Twitter and on the Kerrisdale website.
SahmAdrangi made a big splash in the marketplace by shorting and putting under scrutiny Chinese companies that were fraudulent. These companies included China-Biotics, China Marine Food Group, Lihua International and several other Chinese companies in the years 2019 and 2011. Many of these companies then became the parties to enforcement actions by the Securities and Exchange Commission.
Kerrisdale Capital has become known more and more for the content of its research, especially in the biotechnology area. They have published information that has had a meaningful impact on such companies as Aafgen, Unilife, Bavarian Nordic, and Sage Therapeutics. Another sector that has come forth from the Kerrisdale research efforts is the mining sector. Some of the areas have been called into question with a focus on companies such as Northern Dynasty Minerals, First Majestic Silver, and other similar companies.
The telecommunications area has also drawn attent to the microscope of Kerrisdale’s with focus on ViaSat, Inc., Dish Network, and Globalstar. These reports have resulted in filings with the FCC along with meetings with the FCC.
Adrangi has been a featured speaker and many conferences as well as being featured on Bloomberg, CNBC, and other financial TV programs. He has also been featured in the Wall Street Journal, the Washington Post, BusinessWeek and the New York Times.